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Objectives
The effectiveness of bracing patients with adolescent idio-
pathic scoliosis (AIS) has not been convincingly estab-
lished due to lack of Randomised Controlled Trials (RCT).
The aim of this study is to evaluate whether bracing
patients with AIS in an early stage will result in at least five
degrees less mean progression of the curvature compared
to the control group after two years of follow up.
Study design
Ten Dutch hospitals will participate in this (RCT). Eligible
patients are girls and boys with AIS, aged eight to fifteen
years old, who have not yet been treated by bracing or sur-
gery and for whom further growth of physical height is
still expected (Risser sign <3). The Cobb angle of the eligi-
ble patient should either be minimally twenty-two and
maximally twenty-nine degrees with established progres-
sion of more than five degrees, or should be minimally
thirty and maximally thirty-five degrees (established pro-
gression for the latter is not necessary). A total of 100
patients will be included in this trial. The intervention
group will be treated with full-time Boston brace wear; the
control group will not be braced. Every four months, a
physical and an X-ray examination will take place for each
patient.
Main outcomes
Cobb angle two years after inclusion and quality of life
outcomes.
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